New drug combo aims to keep myeloma at bay after transplant

NCT ID NCT05344833

First seen Feb 24, 2026 · Last updated Apr 22, 2026 · Updated 7 times

Summary

This study is testing whether a two-drug maintenance therapy can help control multiple myeloma in patients who still have small amounts of cancer cells after a stem cell transplant. The treatment involves regular infusions of one drug and daily pills of another, taken long-term to try to keep the cancer from returning. Researchers want to see if this approach can eliminate the remaining cancer cells and help patients live longer without their disease getting worse.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huntsman Cancer Institute

    RECRUITING

    Salt Lake City, Utah, 84112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.